Investing
76 Articles
Stocks are down midday Monday, with the Dow Jones Industrial Average down 0.30%, the Nasdaq down 0.22% and the S&P 500…
When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Tuesday.…
The three major US stock indexes opened slightly higher this morning, but the DJIA almost immediately turned south and remained…
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) took a rather sharp beating yesterday on word that it was going to have a…
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) may have interrupted its rally with a proposed offering of 7 million shares of common…
Biotech is about to become even less of a diversified sector due to mergers and acquisitions. Genzyme Corporation (NASDAQ: GENZ)…
Here are some of the top stories affecting key drug and biotech stocks this Friday. We also have links through…
Here are some of the top stories affecting key drug and biotech stocks that have links through to more in-depth…
Here are some of the top stories affecting key drug and biotech stocks that are covered in-depth today at BioHealthInvestor.com:…
Alnylam (Nasdaq: ALNY) leads a short list of some of the fastest-growing biotech stocks where analyst estimate revisions continue to…
These are some of the top pre-market analyst upgrades and positive research calls we have seen from Wall Street research…
These are some of the early analyst downgrades or negative calls we are seeing this Wednesday in early pre-market hours:…
We just saw a report out of Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) that may get traders moving on both sides…
Below are some of the news items affecting shares of biotech stocks: Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) is enjoying upgrades…
Our top personal finance-related articles today. Your wallet will thank you later.